The anti-tumor protective effect in vivo by Rb9 involved mainly dendritic cells, T cell effector lymphocytes, cytokines, and several regulatory mechanisms of which the MIF-CD74 interaction appears to be most relevant. The gene discussed is MIF; the disease is neoplasm.